Zdrowie i gospodarka · 07/06/2002

FDA Announces Collection of Information for OMB Review

The Food and Drug Administration (FDA) is requesting public comment on proposed changes to its licensing procedures, including the submission of biologics license applications and labeling forms, as part of its efforts to comply with the Paperwork Reduction Act of 1995.